Trial intelligence / Profile preview

Fluvoxamine for prevention of postoperative delirium in older adults undergoing non-cardiac surgery

ACTRN12622000862741Phase 3Recruiting

Sponsor
Royal Prince Alfred Hospital
Start
Sep 2023
Modality
Small Molecules
Countries
2
01

Overview

Phase 3, randomised, double-blind trial in delirium comparing Fluvoxamine with Placebo (2 arms). Primary endpoint: Feasibility: eligible participants enrolled per month. Started Sep 2023; status: recruiting.

02

Drugs

fluvoxamine
03

Conditions

delirium

Beyond the preview

Go deeper on ACTRN12622000862741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12622000862741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call